Literature DB >> 6619553

Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum.

J P Klerx, C J Beukelman, H Van Dijk, J M Willers.   

Abstract

A sensitive colorimetric microassay for determining haemolytic complement activity was devised. It is carried out in U-welled microtitre dishes covered with plastic tape, which are incubated in a waterbath and subsequently centrifuged. The supernatant is transferred to flat-bottomed microtitre dishes and haemolysis is estimated by automatic measuring of the absorption using an interference filter of 405 nm in a Titertek Multiskan. Advantages of the method described are saving time and materials, and avoiding the use of radioactive nuclides. This microassay may therefore be a useful substitute for macro and semi-micro tests for colorimetric determination of serum complement activity and for microassays based on the release of a radio-isotope.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619553     DOI: 10.1016/0022-1759(83)90425-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  34 in total

1.  Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.

Authors:  C J de Haas; E M van Leeuwen; T van Bommel; J Verhoef; K P van Kessel; J A van Strijp
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Intestinal bacterial metabolism and anti-complement activities of three major components of the seeds of Entada phaseoloides.

Authors:  Shihua Xing; Mengyue Wang; Ying Peng; Yuqiong Dong; Xiaobo Li
Journal:  J Nat Med       Date:  2014-11-15       Impact factor: 2.343

3.  Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.

Authors:  C W van den Berg; P Démant; P C Aerts; H Van Dijk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.

Authors:  J A van Strijp; K P van Kessel; L A Miltenburg; A C Fluit; J Verhoef
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  Inhibition of human complement by beta-glycyrrhetinic acid.

Authors:  B H Kroes; C J Beukelman; A J van den Berg; G J Wolbink; H van Dijk; R P Labadie
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

6.  Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus.

Authors:  Mark Throsby; Cecile Geuijen; Jaap Goudsmit; Arjen Q Bakker; Jehanara Korimbocus; R Arjen Kramer; Marieke Clijsters-van der Horst; Maureen de Jong; Mandy Jongeneelen; Sandra Thijsse; Renate Smit; Therese J Visser; Nora Bijl; Wilfred E Marissen; Mark Loeb; David J Kelvin; Wolfgang Preiser; Jan ter Meulen; John de Kruif
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  The active glycosides from Urtica fissa rhizome decoction.

Authors:  Mengyue Wang; Ying Zhang; Hao Zhang; Xiaoru Feng; Xiaobo Li
Journal:  J Nat Med       Date:  2018-01-13       Impact factor: 2.343

8.  Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.

Authors:  W T Jansen; J Gootjes; M Zelle; D V Madore; J Verhoef; H Snippe; A F Verheul
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.

Authors:  R W Vreede; J Leuvenink; A S Bouter; E C Brouwer; J H Marcelis; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

10.  Induction of active immunological hypo/non-responsiveness to C5 in adult C5-deficient DBA/2 mice.

Authors:  C W van den Berg; F M Hofhuis; P M Rademaker; H van Dijk
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.